ASTCT (@astct) 's Twitter Profile
ASTCT

@astct

The American Society for Transplantation and Cellular Therapy

Scientific Journal: @ASTCT_Journal

ID: 1379457751

linkhttp://www.astct.org calendar_today25-04-2013 13:19:48

7,7K Tweet

11,11K Takipçi

451 Takip Edilen

ASTCT (@astct) 's Twitter Profile Photo

Deadline extended ‼️ The deadline to submit an abstract for the ASTCT + EBMT #RelapseConference25 to June 2. Showcase your relapse post-transplant-related findings this fall in Madrid: ow.ly/7YN850VSX4n

Deadline extended ‼️ The deadline to submit an abstract for the ASTCT + EBMT
 #RelapseConference25 to June 2. Showcase your relapse post-transplant-related findings this fall in Madrid: ow.ly/7YN850VSX4n
ASTCT (@astct) 's Twitter Profile Photo

Join the APP SIG for a webinar focused on addressing the unique needs of LGBTQI+ individuals in cancer care, hosted by Dr. Kelly Haviland. Dr. Haviland's research has been instrumental in improving care for this population. Register for free: ow.ly/gCjc50VSGEM

Join the APP SIG for a webinar focused on addressing the unique needs of LGBTQI+ individuals in cancer care, hosted by Dr. Kelly Haviland. Dr. Haviland's research has been instrumental in improving care for this population. Register for free: ow.ly/gCjc50VSGEM
ASTCT (@astct) 's Twitter Profile Photo

Join the APP SIG for a webinar focused on addressing the unique needs of LGBTQI+ individuals in cancer care, hosted by Dr. Kelly Haviland. Dr. Haviland's research has been instrumental in improving care for this population. Register for free: ow.ly/gCjc50VSGEM

Join the APP SIG for a webinar focused on addressing the unique needs of LGBTQI+ individuals in cancer care, hosted by Dr. Kelly Haviland. Dr. Haviland's research has been instrumental in improving care for this population. Register for free: ow.ly/gCjc50VSGEM
ASTCT (@astct) 's Twitter Profile Photo

Join the APP SIG for a webinar this Thursday focused on addressing the unique needs of LGBTQI+ individuals in cancer care, hosted by Dr. Kelly Haviland. Register for free: ow.ly/gCjc50VSGEM

Join the APP SIG for a webinar this Thursday focused on addressing the unique needs of LGBTQI+ individuals in cancer care, hosted by Dr. Kelly Haviland. Register for free: ow.ly/gCjc50VSGEM
ASTCT (@astct) 's Twitter Profile Photo

Join the APP SIG for a webinar tomorrow focused on addressing the unique needs of LGBTQI+ individuals in cancer care, hosted by Dr. Kelly Haviland. Register for free: ow.ly/gCjc50VSGEM

Join the APP SIG for a webinar tomorrow focused on addressing the unique needs of LGBTQI+ individuals in cancer care, hosted by Dr. Kelly Haviland. Register for free: ow.ly/gCjc50VSGEM
ASTCT (@astct) 's Twitter Profile Photo

Researchers in Thailand demonstrated that haplo-HSCT, combined with PTCy, is a feasible and effective treatment for hematologic malignancies even in resource-limited settings. Read more on Nucleus: ow.ly/tFfU50VW43x #GVHD

Researchers in Thailand demonstrated that haplo-HSCT, combined with PTCy, is a feasible and effective treatment for hematologic malignancies even in resource-limited settings. Read more on Nucleus: ow.ly/tFfU50VW43x #GVHD
ASTCT (@astct) 's Twitter Profile Photo

Deadline extended ‼️ The deadline to submit an abstract for the ASTCT + EBMT #RelapseConference25 to June 2. Showcase your relapse post-transplant-related findings this fall in Madrid: ow.ly/7YN850VSX4n

Deadline extended ‼️ The deadline to submit an abstract for the ASTCT + EBMT
 #RelapseConference25 to June 2. Showcase your relapse post-transplant-related findings this fall in Madrid: ow.ly/7YN850VSX4n
ASTCT (@astct) 's Twitter Profile Photo

In this episode of ASTCT Talks, Dr. Shernan Holtan interviews Dr. Andrew Lin from Memorial Sloan Kettering Cancer Center on the role of tacrolimus levels in GVHD prophylaxis within the PTCy era. Listen at the link here or wherever you get podcasts: ow.ly/LNrj50VW3YU

In this episode of ASTCT Talks, Dr. Shernan Holtan interviews Dr. Andrew Lin from Memorial Sloan Kettering Cancer Center on the role of tacrolimus levels in GVHD prophylaxis within the PTCy era. Listen at the link here or wherever you get podcasts: ow.ly/LNrj50VW3YU
ASTCT (@astct) 's Twitter Profile Photo

Have you seen the new look and features of our practice guidelines app? Search "ASTCT Practice Guidelines" in your devices app store to download now.

Have you seen the new look and features of our practice guidelines app? Search "ASTCT Practice Guidelines" in your devices app store to download now.
touchHAEMATOLOGY (@touchhaema) 's Twitter Profile Photo

🧬 Cellular therapy beyond cancer? Dr David Porter shares how these treatments are expanding into autoimmune disease & more — plus ASTCT’s roadmap to 2030. 🔗 touchhaematology.com/insight/breaki… #CellTherapy #CAR_T #AutoimmuneDiseases #ASTCT #touchHAEMATOLOGY

🧬 Cellular therapy beyond cancer?

Dr David Porter shares how these treatments are expanding into autoimmune disease & more — plus ASTCT’s roadmap to 2030.

🔗 touchhaematology.com/insight/breaki…

#CellTherapy #CAR_T #AutoimmuneDiseases #ASTCT #touchHAEMATOLOGY
ASTCT (@astct) 's Twitter Profile Photo

ASTCT recently released a special issue of Transplantation and Cellular Therapy dedicated to the latest research, challenges and innovations in cGVHD management. This supplement is supported by an educational grant from Sanofi/US: ow.ly/vga550U7lLC

ASTCT recently released a special issue of Transplantation and Cellular Therapy dedicated to the latest research, challenges and innovations in cGVHD management. This supplement is supported by an educational grant from Sanofi/US: ow.ly/vga550U7lLC
ASTCT (@astct) 's Twitter Profile Photo

Join the Pharmacy SIG on June 11 for the next journal club! This webinar consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q & A session. Register now: ow.ly/HY5a50VWsRz

Join the Pharmacy SIG on June 11 for the next journal club! This webinar consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q & A session. Register now: ow.ly/HY5a50VWsRz
ASTCT (@astct) 's Twitter Profile Photo

Created with content from our New Developments in CAR T webinar series, this infographic features key info about point-of-care as a mechanism for improving access. View the full series of infographics: ow.ly/wv3X50UtOaV

Created with content from our New Developments in CAR T webinar series, this infographic features key info about point-of-care as a mechanism for improving access. View the full series of infographics: ow.ly/wv3X50UtOaV
ASTCT (@astct) 's Twitter Profile Photo

Deadline extended ‼️ The deadline to submit an abstract for the ASTCT + EBMT #RelapseConference25 to June 2. Showcase your relapse post-transplant-related findings this fall in Madrid: ow.ly/7YN850VSX4n

Deadline extended ‼️ The deadline to submit an abstract for the ASTCT + EBMT
 #RelapseConference25 to June 2. Showcase your relapse post-transplant-related findings this fall in Madrid: ow.ly/7YN850VSX4n
ASTCT (@astct) 's Twitter Profile Photo

The Gene Therapy Summit is returning to Boston this fall! The goal of the Summit is to explore how the strengths of ASTCT centers & members can be leveraged to bring effective therapies to patients & advance the field of ex vivo gene therapy. Learn more: ow.ly/OYSb50VW4lK

The Gene Therapy Summit is returning to Boston this fall! The goal of the Summit is to explore how the strengths of ASTCT centers & members can be leveraged to bring effective therapies to patients & advance the field of ex vivo gene therapy. Learn more: ow.ly/OYSb50VW4lK
touchHAEMATOLOGY (@touchhaema) 's Twitter Profile Photo

🧬 Cell therapy is evolving beyond cancer. Dr David Porter, ASTCT President, shares priorities on expanding access, collaboration, and the roadmap to 2030. 🔗 touchhaematology.com/insight/breaki… ASTCT #CellTherapy #CAR_T #AutoimmuneDiseases #ASTCT #touchHAEMATOLOGY

🧬 Cell therapy is evolving beyond cancer. Dr David Porter, ASTCT President, shares priorities on expanding access, collaboration, and the roadmap to 2030.

🔗 touchhaematology.com/insight/breaki…

<a href="/ASTCT/">ASTCT</a>
#CellTherapy #CAR_T #AutoimmuneDiseases #ASTCT #touchHAEMATOLOGY
ASTCT (@astct) 's Twitter Profile Photo

📆 Save the date: #CEC25 will be held September 29-30 at the Hilton Fort Worth in Texas. If you are an APP, nurse or fellow looking to build a deeper understanding of complications of #HCT & cell therapies, you won't want to miss this conference. ow.ly/vGiS50W3L05

📆 Save the date: #CEC25 will be held September 29-30 at the Hilton Fort Worth in Texas. If you are an APP, nurse or fellow looking to build a deeper understanding of complications of #HCT &amp; cell therapies, you won't want to miss this conference. ow.ly/vGiS50W3L05
ASTCT (@astct) 's Twitter Profile Photo

Join the Pharmacy SIG on June 11 for the next journal club! This webinar consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q & A session. Register now: ow.ly/HY5a50VWsRz

Join the Pharmacy SIG on June 11 for the next journal club! This webinar consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q &amp; A session. Register now: ow.ly/HY5a50VWsRz
ASTCT (@astct) 's Twitter Profile Photo

In the latest ASTCT Talks episode, Dr. Taha Al-Juhaishi welcomes Dr. Marcos de Lime to explore the rapidly evolving field of homegrown CAR-T therapies. Listen now on the ASTCT website or wherever you access podcasts: ow.ly/pKZH50W5vbO

In the latest ASTCT Talks episode, Dr. Taha Al-Juhaishi welcomes Dr. Marcos de Lime to explore the rapidly evolving field of homegrown CAR-T therapies. Listen now on the ASTCT website or wherever you access podcasts: ow.ly/pKZH50W5vbO
ASTCT (@astct) 's Twitter Profile Photo

Applications are open for the 2026 International Trainee Observership Program. One international trainee from a low/mid-income country will participate in 4 week-long observership at the University of California Health - Irvine. 📆 Deadline to apply: Friday, June 13 ow.ly/Ih0650VK0vn

Applications are open for the 2026 International Trainee Observership Program. One international trainee from a low/mid-income country will participate in 4 week-long observership at the <a href="/UofCAHealth/">University of California Health</a> - Irvine. 

📆 Deadline to apply: Friday, June 13
ow.ly/Ih0650VK0vn